North America Hemostatic Sealants in Arterial Surgery Market - Size, Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Hemostatic Sealants in Arterial Surgery Market Overview

Hemostatic sealants play an essential role in improving outcomes during vascular surgery by supporting efficient surgical bleeding control, reducing procedure-related complications, and enhancing operative precision. Advancements in fibrin sealants and topical hemostats continue to strengthen their clinical adoption across arterial procedures. The market is driven by the growing volume of complex vascular interventions, increasing preference for advanced hemostatic technologies, and continuous product innovation. The market is poised to reach USD 432.13 Million by 2035, supported by expanding healthcare infrastructure, favorable reimbursement frameworks, and rising demand for effective intraoperative bleeding management.

North America Hemostatic Sealants in Arterial Surgery Market Growth Analysis and Key Influencers

North America Hemostatic Sealants in Arterial Surgery Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

North America Hemostatic Sealants in Arterial Surgery Market Growth Drivers

Rising Peripheral Artery Disease Burden Strengthens North America Hemostatic Sealants in Arterial Surgery Market Value

The increasing prevalence of peripheral artery disease (PAD) is driving the demand for advanced hemostatic solutions in arterial surgeries across North America. A higher number of vascular procedures required for PAD management is increasing the need for effective bleeding control products that support surgical efficiency and patient outcomes. According to The SAGE Group, the number of U.S. citizens with PAD has increased from 11 million to over 22 million since 1995, creating a significant healthcare burden. This growing disease burden is expected to support market expansion.

North America Hemostatic Sealants in Arterial Surgery Market Restraints

High Procedural Costs and Limited Accessibility are Constraining Market Expansion

The high cost associated with advanced sealants, specialized surgical equipment, and complex arterial procedures continues to limit broader product adoption across healthcare facilities. Additional challenges, including reimbursement constraints, budgetary pressures, and the requirement for specialized surgical expertise, may discourage the widespread implementation of premium solutions. These factors collectively restrict market penetration and may slow the pace of overall market expansion.

North America Hemostatic Sealants in Arterial Surgery Market Opportunities

Advancements in Vascular Closure Technologies are Creating Significant Market Potential

Continuous innovation in vascular closure technologies is creating favorable prospects for the market by improving procedural efficiency, reducing recovery time, and enhancing clinical outcomes. For example, in July 2024, Cordis received FDA approval for its MYNX CONTROL™ VENOUS Vascular Closure Device, demonstrating continued innovation in vascular intervention technologies. Such advancements are expected to complement arterial surgical procedures, encourage the adoption of advanced sealant technologies, and support sustained market expansion.

North America Hemostatic Sealants in Arterial Surgery Market Trends

The market is witnessing several trends, including technological innovation and expanding clinical applications of surgical sealants.

Expanding Clinical Indications for Hemostatic Sealants are Enhancing Market Landscape

The increasing expansion of clinical indications for advanced surgical sealants is emerging as a key trend supporting the market by broadening their application across diverse patient populations and surgical settings. For example, in September 2024, the U.S. Food and Drug Administration approved the expanded pediatric indication for Vistaseal, reflecting continued progress in sealant innovation. Such regulatory advancements are expected to strengthen product adoption and contribute to sustained market growth.

North America Hemostatic Sealants in Arterial Surgery Market Share

Aortic Aneurysms Segment to Drive Market Growth by Disease Indication

The market is segmented based on disease indication into aortic aneurysms, peripheral artery disease, carotid artery disease, and others. Among these, aortic aneurysms are expected to lead the market due to the increasing prevalence of aneurysmal conditions requiring vascular surgical procedures and effective bleeding control solutions such as hemostatic sealants. According to the University of Utah, each year, about 200,000 people in the U.S. are diagnosed with an abdominal aortic aneurysm, a bulging of the large blood vessel running through the abdomen. This rising disease is expected to support the adoption of hemostatic sealants in arterial surgeries.

North America Hemostatic Sealants in Arterial Surgery Market Analysis by Region

The regions covered in the market include the United States and Canada. Among these, the United States is expected to maintain its leading position owing to its advanced healthcare infrastructure, high adoption of innovative vascular surgical technologies, favorable regulatory environment, and strong presence of leading medical device manufacturers. Continuous investment in surgical innovation and expanding access to advanced vascular care are expected to further strengthen the country's market leadership.

Leading Players in the North America Hemostatic Sealants in Arterial Surgery Market

North America Hemostatic Sealants in Arterial Surgery Market Segmentation

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Questions Answered in the North America Hemostatic Sealants in Arterial Surgery Market Report

• What was the North America hemostatic sealants in arterial surgery market value in 2025?
• What is the North America hemostatic sealants in arterial surgery market forecast outlook for 2026-2035?
• What are the major factors aiding the North America hemostatic sealants in arterial surgery market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major North America hemostatic sealants in arterial surgery market trends?
• Which product type is expected to dominate the market segment?
• Which surgical application is projected to lead the market segment?
• Which disease indication is anticipated to drive the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the North America hemostatic sealants in arterial surgery market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews conducted with vascular surgeons, cardiovascular surgeons, arterial surgery specialists, hospital procurement managers, and medical device industry experts across North America to assess adoption trends, clinical applications, procurement patterns, and demand for hemostatic sealants in arterial procedures. Insights were gathered from experts associated with organizations such as the Society for Vascular Surgery (SVS), American College of Surgeons (ACS), and American Heart Association (AHA).
• Secondary Research: Analysis of peer-reviewed publications from journals including the Journal of Vascular Surgery, Annals of Vascular Surgery, and Journal of Thoracic and Cardiovascular Surgery; regulatory information from the U.S. Food and Drug Administration (FDA) and Health Canada; clinical trial databases such as ClinicalTrials.gov; epidemiological data from CDC, NIH, and WHO; and company sources, including product portfolios, annual reports, regulatory updates, press releases, and official websites of key players such as Ethicon, Inc., Baxter International Inc., Corza Medical Inc., and Artivion, Inc.
• Validation: Quantitative market estimates were validated through top-down and bottom-up market modeling, data triangulation, and expert feedback loops to ensure accuracy and reliability.